Skip to main content
Home / Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 1, Number 2

Current Drug Targets - Cardiovascular & Hematological Disorders is now published as Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders).

Publisher: Bentham Science Publishers

Volume 1, Number 2, 2001

Reviews

Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders
pp. 59-74(16)
Authors: Boffa, M.B.; Nesheim, M.E.; Koschinsky, M.L.

Favourites:
ADD

Contributory Role of Matrix Metalloproteinases in Cardiovascular Remodeling
pp. 75-91(17)
Authors: Gunasinghe, S.K.; Ikonomidis, J.; Spinale, F.G.

Favourites:
ADD

Apolipoprotein E: Possible Therapeutic Target for Atherosclerosis
pp. 93-106(14)
Authors: Bocksch, L.; Stephens, T.; Lucas, A.; Singh, B.

Favourites:
ADD

Reduction and Prevention of the Cardiovascular Sequelae of the Insulin Resistance Syndrome
pp. 107-120(14)
Author: Russell, J.C.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content